637334-45-3(Ocrelizumab)

Basic information Supplier

637334-45-3 Basic informationMore

Product Name:Ocrelizumab
Synonyms: Ocrelizumab Research Grade Ocrelizumab(DHC90702) Ocrelizumab (anti-CD20)
CAS:637334-45-3
MF:C19H16N2O5
MW:0
EINECS:
Mol File:Mol File

Browse by Nationality 637334-45-3 Suppliers >China suppliers

Recommend You Select Member Companies

Company Name:BOC Sciences
Tel:
Nationality:USA
Products Intro:Product Name:ocrelizumab
CAS:637334-45-3
Remarks:Ocrelizumab is an anti-CD20 monoclonal antibody developed by Genentech to treat relapsing and primary progressive forms of multiple sclerosis (MS).
CB Index:65
Related Information:Catalog(0)

Company Name:Aladdin Scientific
Tel:+1-+1(833)-552-7181
Nationality:United States
Products Intro:Product Name:Ocrelizumab (anti-CD20)
CAS:637334-45-3
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:$59.9/100μg;$279.9/1mg;$739.9/5mg;$1189.9/10mg;Bulk package Remarks:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
CB Index:58
Related Information:Catalog(57511)